Related Topics
Why ‘breakthrough’ COVID-19 cases happen
In spite of strongly protective vaccines, some “breakthrough” COVID-19 infections are to be expected because no vaccine is 100% effective.
Vaccine push slows COVID deaths among Brazil’s elderly
Early efforts to vaccinate elderly people in Brazil against COVID-19 appear to be preventing deaths, according to new research. The study, co-authored by Marcia Castro, Andelot Professor of Demography and chair of the Department of Global Health and…
COVID-19 burden higher in socially disadvantaged regions in Japan
In Japan, more COVID-19 cases and deaths have occurred in prefectures with lower household incomes and a higher unemployment rate, among other socioeconomic factors.
Atul Gawande nominated for senior USAID post
Public health expert, surgeon, and writer Atul Gawande has been nominated by President Joe Biden to lead global health development at the U.S. Agency for International Development (USAID).
The danger of the Delta variant
The Delta variant of the coronavirus has been spreading rapidly throughout the U.S. and worldwide. Epidemiologist William Hanage discusses the threat.
New method accurately reflects hotspots in epidemics
Monitoring epidemics is essential for understanding how well public health interventions are working and where to distribute extra resources For immediate release: Thursday, June 3, 2021 Boston, MA – A new method to monitor epidemics like COVID-19 gives…
Hard lessons in the midst of hope
COVID-19 vaccines are rolling out, but variants continue to spread and public health systems around the world remain strained. Experts from across the Harvard Chan School reflect on the pandemic and what it means for the future of…
Helping medical providers discuss COVID-19 vaccines with hesitant patients
A new toolkit created by a team at Ariadne Labs aims to help increase public confidence in COVID-19 vaccines.
Leading coronavirus scientist, Kizzmekia S. Corbett, to join Harvard T.H. Chan School of Public Health to continue vaccine development research
Leading coronavirus scientist Kizzmekia S. Corbett is joining Harvard Chan School as an assistant professor to continue vaccine development research.
Nurses key to delivering vaccines in developing countries
At a nursing leadership event, speakers cited nurses' critical role in vaccination campaigns, and called for vaccine equity among wealthy and developing nations.
